PLASMA IMMUNOREACTIVE CALCITONIN AND BONE-DISEASE IN DIALYZED PATIENTS

PLASMA IMMUNOREACTIVE CALCITONIN AND BONE-DISEASE IN DIALYZED PATIENTS

Bibliographic Details
Main Authors:	Heynen, G, Kanis, J, Earnshaw, M, Woods, C, Oliver, D, Ledingham, J, Walton, R, Russell, R
Format:	Journal article
Published:	1976

Similar Items

EVIDENCE THAT ENDOGENOUS CALCITONIN PROTECTS AGAINST RENAL BONE-DISEASE
by: Heynen, G, et al.
Published: (1976)

CALCITONIN, BONE-DISEASE, AND CHRONIC RENAL-FAILURE
by: Cundy, T, et al.
Published: (1978)

The possible role of calcitonin deficiency in the development of bone disease due to chronic renal failure.
by: Kanis, J, et al.
Published: (1977)

CALCITONINS ROLE - REPLY
by: Kanis, J, et al.
Published: (1977)

Changes in histologic and biochemical indexes of bone turnover after bilateral nephrectomy in patients on hemodialysis. Evidence for a possible role of endogenous calcitonin.
by: Kanis, J, et al.
Published: (1977)

Correlation of clinical, biochemical and skeletal responses to 1alpha-hydroxyvitamin D3 in renal bone disease.
by: Kanis, J, et al.
Published: (1977)

Factors influencing the response to 1alpha-hydroxyvitamin D3 in patients with renal bone disease.
by: Kanis, J, et al.
Published: (1977)

VITAMIN-DS, MINERALS AND RENAL BONE-DISEASE
by: Kanis, J, et al.
Published: (1979)

Osteomalacia in renal disease.
by: Kanis, J, et al.
Published: (1980)

Treatment of renal bone disease with 1 alpha-hydroxylated derivatives of vitamin D3. Clinical, biochemical, radiographic and histological responses.
by: Kanis, J, et al.
Published: (1979)

APPOSITIONAL RATES IN BONE IN PATIENTS WITH CHRONIC RENAL-DISEASE
by: Earnshaw, M, et al.
Published: (1979)

An estimate of the turnover rate of bone-derived plasma alkaline phosphatase in Paget's disease.
by: Walton, R, et al.
Published: (1975)

Renal osteodystrophy in nondialysed adolescents. Long-term treatment with 1alpha-hydroxycholecalciferol.
by: Kanis, J, et al.
Published: (1977)

Loss of metacarpal and iliac bone in chronic renal failure: influence of haemodialysis, parathyroid activity, type of renal disease, physical activity and heparin consumption.
by: Henderson, R, et al.
Published: (1979)

Histological measurements in Paget's disease of bone.
by: Walton, R, et al.
Published: (1977)

VITAMIN-D IN CHRONIC RENAL-FAILURE
by: Kanis, J, et al.
Published: (1979)

THERAPEUTIC ADVANTAGE OF 1-ALPHA-HYDROXYLATED COMPOUNDS OVER VITAMIN-D
by: Kanis, J, et al.
Published: (1977)

Dialyzer Reuse Impact on Dialyzer Efficiency, Patient Morbidity and Mortality and Cost Effectiveness
by: Mitwalli Ahmed, et al.
Published: (2001-01-01)

THE PATHO-PHYSIOLOGY OF HYPERCALCEMIA
by: Kanis, J, et al.
Published: (1980)

Resistance of dialyzed patients to erythropoietin
by: Michelle Teodoro Alves, et al.
Published: (2015-06-01)

Diffusion in Tube Dialyzer
by: Yohannes Nigatie
Published: (2017-09-01)

Assessment of dialyzer surface in online hemodiafiltration; objective choice of dialyzer surface area
by: Francisco Maduell, et al.
Published: (2015-05-01)

Estimation of calcitonin and calcitonin gene-related peptide-α in bone calcification in quail during laying period
by: Hadeel M. Hameed, et al.
Published: (2025-01-01)

RESPONSE OF THE BONE AND KIDNEY TO EHDP IN MAN
by: Russell, R, et al.
Published: (1979)

Effects of 1,25-dihydroxycholecalciferol on calcium absorption, muscle weakness, and bone disease in chronic renal failure.
by: Henderson, R, et al.
Published: (1974)

Biochemical markers of bone turnover in the diagnosis of renal osteodystrophy in dialyzed children
by: Esra Baskin, et al.
Published: (2004-01-01)

Sleep disorders in chronically dialyzed patients
by: Agnieszka Pluta, et al.
Published: (2018-10-01)

Sleep disorders in chronically dialyzed patients
by: Agnieszka Pluta, et al.
Published: (2018-10-01)

Carboxypeptidase B1 in dialyzed chronic kidney disease patients
by: Matej Stančík, et al.
Published: (2025-02-01)

Efficacy of Calcitonin on Bone Healing in Guinea Pigs
by: MA Erfani, et al.
Published: (2006-07-01)

Hemodynamic effects of succinate-containing dialyzing solution
by: A V Smirnov, et al.
Published: (2015-06-01)

The importance of psychological support for end-stage renal disease dialyzed patients
by: M. Regaya, et al.
Published: (2021-04-01)

NLRP3 inflammasome activation in dialyzed chronic kidney disease patients.
by: Simona Granata, et al.
Published: (2015-01-01)

Dietary intake of tyrosine and phenylalanine, and p-cresyl sulfate plasma levels in non-dialyzed patients with chronic kidney disease
by: Andressa Louzada Frauche Fernandes, et al.

Potential study of regenerating waste dialyzer
by: Maryani, Basri
Published: (2014)

Regeneration and recycling hemodialysis membrane dialyzer
by: Siti Norsita, Mohd Rawi
Published: (2013)

Dialyzer reuse; effect on efficiency and biocompatibility
by: Atef H Huzayin, et al.
Published: (1999-01-01)

Calcitonin and Bone Physiology: In Vitro, In Vivo, and Clinical Investigations
by: Jingbo Xie, et al.
Published: (2020-01-01)

PERCUTANEOUS TREATMENT OF ANEURYSMAL BONE CYST WITH CALCITONIN AND METHYLPREDNISOLONE
by: Marcelo Bragança dos Reis Oliveira, et al.
Published: (2018-10-01)

Calcitonin in osteogenesis imperfecta.
by: Smith, R, et al.
Published: (1973)